NASDAQ : BFRIW

Biofrontera Inc.

$0.0231 USD

-$0.01 (-18.95%)

Volume
1.78K
Average Volume
5.7K
Market Capitalization
$8.9M
P/E Ratio
-0.97
Dividend Yield
0.00%
Price Target
Year High
$0.10
Year Low
$0.02
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.20
Company Overview

NASDAQ

Hermann Luebbert

Drug Manufacturers - Specialty & Generic

Healthcare

BFRIW

92

US

USD

781-245-1325

09077D118

0001858685

Liquidity Metrics

1.27

1.20

1.09

0.58

0.00

Sales & Valuation

$41.7M

0.32

2.10

-1.50

-0.80

Profitability

-$0.9

-$10.54M

-25.66%

-25.60%

-476.72%

-44.72%

P/E Metrics

-0.97

-0.03

-0.03

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-5.80

2/9

$2.24M

$24.79M

$18.72M

-$4.96M

Key Metrics (TTM)

$15.23M

0.35

-1.52

1.20

-476.72%

-62.07%

-87.85%

-67.39%

-85 days

Company Executives
Name Title
Jon Lyons Vice President of Scientific & Medical Affairs
Samantha Widdicombe Senior Vice President of Sales & Strategic Accounts
George Jones Chief Commercial Officer
Erica F. Gates VP of Finance & Principal Accounting Officer
Hermann Luebbert Chief Executive Officer, President & Chairman
Daniel Hakansson Senior Corporate Counsel
Eugene Frederick Leffler Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About Biofrontera Inc. (NASDAQ:BFRIW) Stock

Biofrontera Inc. is a biopharmaceutical firm specializing in the commercialization of pharmaceutical solutions for skin-related ailments across the United States. Its product lineup features Ameluz, a prescription drug employed with the BF-RhodoLED lamp series for photodynamic therapy. This treatment is designed for both localized and broader area management of mild-to-moderate actinic keratosis on the face and scalp. Additionally, the company offers Xepi, a topical, non-fluorinated quinolone that functions by inhibiting bacterial growth to treat impetigo. Established in 2015, Biofrontera Inc. is headquartered in Woburn, Massachusetts. ...

Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

2026-05-21 09:15:00

WOBURN, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.

Frequently Asked Questions

What is the current Biofrontera Inc. (BFRIW) stock price?

Biofrontera Inc.(NASDAQ:BFRIW) stock price is $0.0231 in the last trading session. During the trading session, BFRIW stock reached the peak price of $0.0971 while $0.0231 was the lowest point it dropped to. The percentage change in BFRIW stock occurred in the recent session was --18.95% while the dollar amount for the price change in BFRIW stock was -$0.01.

BFRIW's industry and sector of operation?

The NASDAQ listed BFRIW is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of BFRIW?

Jon Lyons | Vice President of Scientific & Medical Affairs
Samantha Widdicombe | Senior Vice President of Sales & Strategic Accounts
George Jones | Chief Commercial Officer
Erica F. Gates | VP of Finance & Principal Accounting Officer
Hermann Luebbert | Chief Executive Officer, President & Chairman

How many employees does BFRIW have?

Number of BFRIW employees currently stands at 92. BFRIW operates from 120 Presidential Way, Woburn, MA 01801, US.

Link for BFRIW official website?

Official Website of BFRIW is: https://www.biofrontera-us.com

How do I contact BFRIW?

BFRIW could be contacted at phone #781-245-1325 and can also be accessed through its website. BFRIW operates from 120 Presidential Way, Woburn, MA 01801, US.

How many shares of BFRIW are traded daily?

The average number of BFRIW shares traded daily for last 3 months was 5.7K.

What is the market cap of BFRIW currently?

The market value of BFRIW currently stands at $8.9M with its latest stock price at $0.0231